Report Detail
Global IPSC-Derived Pancreatic Beta-Like Cells Market 2026 by Company, Regions, Type and Application, Forecast to 2032
- RnM4732277 |
- 13 August, 2026 |
- Global |
- 84 Pages |
- GIR |
- Other
According to our (Global Info Research) latest study, the global IPSC-Derived Pancreatic Beta-Like Cells market size was valued at US$ 51.45 million in 2025 and is forecast to a readjusted size of US$ 1058 million by 2032 with a CAGR of 53.7% during review period.
iPSC-Derived Islet β-like Cells are insulin-secreting, β-cell–like products generated from induced pluripotent stem cells (iPSCs) through directed differentiation, maturation induction, and quality control processes. These cells are primarily used in cell replacement therapy for type 1 diabetes, pancreatic function research, disease modeling, drug screening, and evaluation of implantation and delivery devices. Key procurement considerations include the parental iPSC line, differentiation maturity, glucose-stimulated insulin secretion capability, cellular purity, residual undifferentiated cell content, post-thaw viability, GMP compatibility, and immune protection strategies. The overall gross margin is approximately 60%.
Demand for iPSC-derived β-like cells is driven by the shift in diabetes management from long-term glycemic control toward functional curative replacement therapies. Patients with type 1 diabetes require lifelong insulin administration, while traditional donor-derived islets are severely limited in supply. iPSCs offer scalable expansion, cell banking potential, and genetic engineering capability, making them a promising large-scale source of β cells. As clinical data accumulate, therapeutic demand is shifting beyond demonstrating insulin secretion toward achieving long-term engraftment, stable glycemic control, and reduced reliance on immunosuppression.
Product development is focused on improving differentiation efficiency, functional maturation, cellular composition consistency, and GMP-scale manufacturing. Leading companies are advancing allogeneic universal donor cells, hypoimmunogenic gene-edited lines, encapsulation devices, and retrievable implant systems. Research-grade products are also widely used in drug screening, toxicity testing, and disease mechanism studies. Future commercialization depends not only on cell products themselves but also on supporting ecosystems such as standardized culture media, key growth factors, automated bioreactor systems, quality release testing, and cold-chain delivery infrastructure.
Regionally, North America and Europe lead in clinical translation, regulatory engagement, and financing activity, while Japan and China are highly active in iPSC foundational research and early clinical exploration. The market still faces challenges related to safety, batch consistency, cost control, immune rejection, and long-term follow-up requirements. However, once regulatory pathways become clearer, both therapeutic diabetes applications and research-grade functional cell markets are expected to significantly expand the broader supply chain opportunity space.
This report is a detailed and comprehensive analysis for global IPSC-Derived Pancreatic Beta-Like Cells market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global IPSC-Derived Pancreatic Beta-Like Cells market size and forecasts, in consumption value ($ Million), 2021-2032
Global IPSC-Derived Pancreatic Beta-Like Cells market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global IPSC-Derived Pancreatic Beta-Like Cells market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global IPSC-Derived Pancreatic Beta-Like Cells market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for IPSC-Derived Pancreatic Beta-Like Cells
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global IPSC-Derived Pancreatic Beta-Like Cells market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Vertex Pharmaceuticals, Aspect Biosystems, Evotec, Sernova, Sana Biotechnology, Century Therapeutics, Takara Bio, Cell-Easy, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
IPSC-Derived Pancreatic Beta-Like Cells market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Therapeutic Cell Products
Research-Grade Beta-Like Cells
Disease Model Cells
Custom Differentiation Services
Other Use Formats
Market segment by Immune Strategy
Allogeneic Unedited Cells
Gene-Edited Hypoimmune Cells
Autologous Patient-Specific Cells
HLA-Matched Banked Cells
Other Immune Strategies
Market segment by Differentiation Maturity
Pancreatic Progenitor Cells
Immature Beta-Like Cells
Functionally Mature Beta-Like Cells
Islet-Like Clusters
Mixed Endocrine Cell Preparations
Market segment by Delivery Format
Naked Cell Suspension
Encapsulated Cells
Device-Loaded Cells
Scaffold-Associated Cells
Other Delivery Formats
Market segment by Application
Type 1 Diabetes Cell Therapy
Insulin-Dependent Diabetes Research
Drug Screening and Toxicity Testing
Disease Modeling and Mechanism Research
Transplantation and Encapsulation Research
Process Development and Quality Control
Market segment by players, this report covers
Vertex Pharmaceuticals
Aspect Biosystems
Evotec
Sernova
Sana Biotechnology
Century Therapeutics
Takara Bio
Cell-Easy
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe IPSC-Derived Pancreatic Beta-Like Cells product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of IPSC-Derived Pancreatic Beta-Like Cells, with revenue, gross margin, and global market share of IPSC-Derived Pancreatic Beta-Like Cells from 2021 to 2026.
Chapter 3, the IPSC-Derived Pancreatic Beta-Like Cells competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and IPSC-Derived Pancreatic Beta-Like Cells market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of IPSC-Derived Pancreatic Beta-Like Cells.
Chapter 13, to describe IPSC-Derived Pancreatic Beta-Like Cells research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of IPSC-Derived Pancreatic Beta-Like Cells by Type
- 1.3.1 Overview: Global IPSC-Derived Pancreatic Beta-Like Cells Market Size by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Global IPSC-Derived Pancreatic Beta-Like Cells Consumption Value Market Share by Type in 2025
- 1.3.3 Therapeutic Cell Products
- 1.3.4 Research-Grade Beta-Like Cells
- 1.3.5 Disease Model Cells
- 1.3.6 Custom Differentiation Services
- 1.3.7 Other Use Formats
- 1.4 Classification of IPSC-Derived Pancreatic Beta-Like Cells by Immune Strategy
- 1.4.1 Overview: Global IPSC-Derived Pancreatic Beta-Like Cells Market Size by Immune Strategy: 2021 Versus 2025 Versus 2032
- 1.4.2 Global IPSC-Derived Pancreatic Beta-Like Cells Consumption Value Market Share by Immune Strategy in 2025
- 1.4.3 Allogeneic Unedited Cells
- 1.4.4 Gene-Edited Hypoimmune Cells
- 1.4.5 Autologous Patient-Specific Cells
- 1.4.6 HLA-Matched Banked Cells
- 1.4.7 Other Immune Strategies
- 1.5 Classification of IPSC-Derived Pancreatic Beta-Like Cells by Differentiation Maturity
- 1.5.1 Overview: Global IPSC-Derived Pancreatic Beta-Like Cells Market Size by Differentiation Maturity: 2021 Versus 2025 Versus 2032
- 1.5.2 Global IPSC-Derived Pancreatic Beta-Like Cells Consumption Value Market Share by Differentiation Maturity in 2025
- 1.5.3 Pancreatic Progenitor Cells
- 1.5.4 Immature Beta-Like Cells
- 1.5.5 Functionally Mature Beta-Like Cells
- 1.5.6 Islet-Like Clusters
- 1.5.7 Mixed Endocrine Cell Preparations
- 1.6 Classification of IPSC-Derived Pancreatic Beta-Like Cells by Delivery Format
- 1.6.1 Overview: Global IPSC-Derived Pancreatic Beta-Like Cells Market Size by Delivery Format: 2021 Versus 2025 Versus 2032
- 1.6.2 Global IPSC-Derived Pancreatic Beta-Like Cells Consumption Value Market Share by Delivery Format in 2025
- 1.6.3 Naked Cell Suspension
- 1.6.4 Encapsulated Cells
- 1.6.5 Device-Loaded Cells
- 1.6.6 Scaffold-Associated Cells
- 1.6.7 Other Delivery Formats
- 1.7 Global IPSC-Derived Pancreatic Beta-Like Cells Market by Application
- 1.7.1 Overview: Global IPSC-Derived Pancreatic Beta-Like Cells Market Size by Application: 2021 Versus 2025 Versus 2032
- 1.7.2 Type 1 Diabetes Cell Therapy
- 1.7.3 Insulin-Dependent Diabetes Research
- 1.7.4 Drug Screening and Toxicity Testing
- 1.7.5 Disease Modeling and Mechanism Research
- 1.7.6 Transplantation and Encapsulation Research
- 1.7.7 Process Development and Quality Control
- 1.8 Global IPSC-Derived Pancreatic Beta-Like Cells Market Size & Forecast
- 1.9 Global IPSC-Derived Pancreatic Beta-Like Cells Market Size and Forecast by Region
- 1.9.1 Global IPSC-Derived Pancreatic Beta-Like Cells Market Size by Region: 2021 VS 2025 VS 2032
- 1.9.2 Global IPSC-Derived Pancreatic Beta-Like Cells Market Size by Region, (2021-2032)
- 1.9.3 North America IPSC-Derived Pancreatic Beta-Like Cells Market Size and Prospect (2021-2032)
- 1.9.4 Europe IPSC-Derived Pancreatic Beta-Like Cells Market Size and Prospect (2021-2032)
- 1.9.5 Asia-Pacific IPSC-Derived Pancreatic Beta-Like Cells Market Size and Prospect (2021-2032)
- 1.9.6 South America IPSC-Derived Pancreatic Beta-Like Cells Market Size and Prospect (2021-2032)
- 1.9.7 Middle East & Africa IPSC-Derived Pancreatic Beta-Like Cells Market Size and Prospect (2021-2032)
2 Company Profiles
- 2.1 Vertex Pharmaceuticals
- 2.1.1 Vertex Pharmaceuticals Details
- 2.1.2 Vertex Pharmaceuticals Major Business
- 2.1.3 Vertex Pharmaceuticals IPSC-Derived Pancreatic Beta-Like Cells Product and Solutions
- 2.1.4 Vertex Pharmaceuticals IPSC-Derived Pancreatic Beta-Like Cells Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Vertex Pharmaceuticals Recent Developments and Future Plans
- 2.2 Aspect Biosystems
- 2.2.1 Aspect Biosystems Details
- 2.2.2 Aspect Biosystems Major Business
- 2.2.3 Aspect Biosystems IPSC-Derived Pancreatic Beta-Like Cells Product and Solutions
- 2.2.4 Aspect Biosystems IPSC-Derived Pancreatic Beta-Like Cells Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Aspect Biosystems Recent Developments and Future Plans
- 2.3 Evotec
- 2.3.1 Evotec Details
- 2.3.2 Evotec Major Business
- 2.3.3 Evotec IPSC-Derived Pancreatic Beta-Like Cells Product and Solutions
- 2.3.4 Evotec IPSC-Derived Pancreatic Beta-Like Cells Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 Evotec Recent Developments and Future Plans
- 2.4 Sernova
- 2.4.1 Sernova Details
- 2.4.2 Sernova Major Business
- 2.4.3 Sernova IPSC-Derived Pancreatic Beta-Like Cells Product and Solutions
- 2.4.4 Sernova IPSC-Derived Pancreatic Beta-Like Cells Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 Sernova Recent Developments and Future Plans
- 2.5 Sana Biotechnology
- 2.5.1 Sana Biotechnology Details
- 2.5.2 Sana Biotechnology Major Business
- 2.5.3 Sana Biotechnology IPSC-Derived Pancreatic Beta-Like Cells Product and Solutions
- 2.5.4 Sana Biotechnology IPSC-Derived Pancreatic Beta-Like Cells Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 Sana Biotechnology Recent Developments and Future Plans
- 2.6 Century Therapeutics
- 2.6.1 Century Therapeutics Details
- 2.6.2 Century Therapeutics Major Business
- 2.6.3 Century Therapeutics IPSC-Derived Pancreatic Beta-Like Cells Product and Solutions
- 2.6.4 Century Therapeutics IPSC-Derived Pancreatic Beta-Like Cells Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 Century Therapeutics Recent Developments and Future Plans
- 2.7 Takara Bio
- 2.7.1 Takara Bio Details
- 2.7.2 Takara Bio Major Business
- 2.7.3 Takara Bio IPSC-Derived Pancreatic Beta-Like Cells Product and Solutions
- 2.7.4 Takara Bio IPSC-Derived Pancreatic Beta-Like Cells Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 Takara Bio Recent Developments and Future Plans
- 2.8 Cell-Easy
- 2.8.1 Cell-Easy Details
- 2.8.2 Cell-Easy Major Business
- 2.8.3 Cell-Easy IPSC-Derived Pancreatic Beta-Like Cells Product and Solutions
- 2.8.4 Cell-Easy IPSC-Derived Pancreatic Beta-Like Cells Revenue, Gross Margin and Market Share (2021-2026)
- 2.8.5 Cell-Easy Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global IPSC-Derived Pancreatic Beta-Like Cells Revenue and Share by Players (2021-2026)
- 3.2 Market Share Analysis (2025)
- 3.2.1 Market Share of IPSC-Derived Pancreatic Beta-Like Cells by Company Revenue
- 3.2.2 Top 3 IPSC-Derived Pancreatic Beta-Like Cells Players Market Share in 2025
- 3.2.3 Top 6 IPSC-Derived Pancreatic Beta-Like Cells Players Market Share in 2025
- 3.3 IPSC-Derived Pancreatic Beta-Like Cells Market: Overall Company Footprint Analysis
- 3.3.1 IPSC-Derived Pancreatic Beta-Like Cells Market: Region Footprint
- 3.3.2 IPSC-Derived Pancreatic Beta-Like Cells Market: Company Product Type Footprint
- 3.3.3 IPSC-Derived Pancreatic Beta-Like Cells Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
- 4.1 Global IPSC-Derived Pancreatic Beta-Like Cells Consumption Value and Market Share by Type (2021-2026)
- 4.2 Global IPSC-Derived Pancreatic Beta-Like Cells Market Forecast by Type (2027-2032)
5 Market Size Segment by Application
- 5.1 Global IPSC-Derived Pancreatic Beta-Like Cells Consumption Value Market Share by Application (2021-2026)
- 5.2 Global IPSC-Derived Pancreatic Beta-Like Cells Market Forecast by Application (2027-2032)
6 North America
- 6.1 North America IPSC-Derived Pancreatic Beta-Like Cells Consumption Value by Type (2021-2032)
- 6.2 North America IPSC-Derived Pancreatic Beta-Like Cells Market Size by Application (2021-2032)
- 6.3 North America IPSC-Derived Pancreatic Beta-Like Cells Market Size by Country
- 6.3.1 North America IPSC-Derived Pancreatic Beta-Like Cells Consumption Value by Country (2021-2032)
- 6.3.2 United States IPSC-Derived Pancreatic Beta-Like Cells Market Size and Forecast (2021-2032)
- 6.3.3 Canada IPSC-Derived Pancreatic Beta-Like Cells Market Size and Forecast (2021-2032)
- 6.3.4 Mexico IPSC-Derived Pancreatic Beta-Like Cells Market Size and Forecast (2021-2032)
7 Europe
- 7.1 Europe IPSC-Derived Pancreatic Beta-Like Cells Consumption Value by Type (2021-2032)
- 7.2 Europe IPSC-Derived Pancreatic Beta-Like Cells Consumption Value by Application (2021-2032)
- 7.3 Europe IPSC-Derived Pancreatic Beta-Like Cells Market Size by Country
- 7.3.1 Europe IPSC-Derived Pancreatic Beta-Like Cells Consumption Value by Country (2021-2032)
- 7.3.2 Germany IPSC-Derived Pancreatic Beta-Like Cells Market Size and Forecast (2021-2032)
- 7.3.3 France IPSC-Derived Pancreatic Beta-Like Cells Market Size and Forecast (2021-2032)
- 7.3.4 United Kingdom IPSC-Derived Pancreatic Beta-Like Cells Market Size and Forecast (2021-2032)
- 7.3.5 Russia IPSC-Derived Pancreatic Beta-Like Cells Market Size and Forecast (2021-2032)
- 7.3.6 Italy IPSC-Derived Pancreatic Beta-Like Cells Market Size and Forecast (2021-2032)
8 Asia-Pacific
- 8.1 Asia-Pacific IPSC-Derived Pancreatic Beta-Like Cells Consumption Value by Type (2021-2032)
- 8.2 Asia-Pacific IPSC-Derived Pancreatic Beta-Like Cells Consumption Value by Application (2021-2032)
- 8.3 Asia-Pacific IPSC-Derived Pancreatic Beta-Like Cells Market Size by Region
- 8.3.1 Asia-Pacific IPSC-Derived Pancreatic Beta-Like Cells Consumption Value by Region (2021-2032)
- 8.3.2 China IPSC-Derived Pancreatic Beta-Like Cells Market Size and Forecast (2021-2032)
- 8.3.3 Japan IPSC-Derived Pancreatic Beta-Like Cells Market Size and Forecast (2021-2032)
- 8.3.4 South Korea IPSC-Derived Pancreatic Beta-Like Cells Market Size and Forecast (2021-2032)
- 8.3.5 India IPSC-Derived Pancreatic Beta-Like Cells Market Size and Forecast (2021-2032)
- 8.3.6 Southeast Asia IPSC-Derived Pancreatic Beta-Like Cells Market Size and Forecast (2021-2032)
- 8.3.7 Australia IPSC-Derived Pancreatic Beta-Like Cells Market Size and Forecast (2021-2032)
9 South America
- 9.1 South America IPSC-Derived Pancreatic Beta-Like Cells Consumption Value by Type (2021-2032)
- 9.2 South America IPSC-Derived Pancreatic Beta-Like Cells Consumption Value by Application (2021-2032)
- 9.3 South America IPSC-Derived Pancreatic Beta-Like Cells Market Size by Country
- 9.3.1 South America IPSC-Derived Pancreatic Beta-Like Cells Consumption Value by Country (2021-2032)
- 9.3.2 Brazil IPSC-Derived Pancreatic Beta-Like Cells Market Size and Forecast (2021-2032)
- 9.3.3 Argentina IPSC-Derived Pancreatic Beta-Like Cells Market Size and Forecast (2021-2032)
10 Middle East & Africa
- 10.1 Middle East & Africa IPSC-Derived Pancreatic Beta-Like Cells Consumption Value by Type (2021-2032)
- 10.2 Middle East & Africa IPSC-Derived Pancreatic Beta-Like Cells Consumption Value by Application (2021-2032)
- 10.3 Middle East & Africa IPSC-Derived Pancreatic Beta-Like Cells Market Size by Country
- 10.3.1 Middle East & Africa IPSC-Derived Pancreatic Beta-Like Cells Consumption Value by Country (2021-2032)
- 10.3.2 Turkey IPSC-Derived Pancreatic Beta-Like Cells Market Size and Forecast (2021-2032)
- 10.3.3 Saudi Arabia IPSC-Derived Pancreatic Beta-Like Cells Market Size and Forecast (2021-2032)
- 10.3.4 UAE IPSC-Derived Pancreatic Beta-Like Cells Market Size and Forecast (2021-2032)
11 Market Dynamics
- 11.1 IPSC-Derived Pancreatic Beta-Like Cells Market Drivers
- 11.2 IPSC-Derived Pancreatic Beta-Like Cells Market Restraints
- 11.3 IPSC-Derived Pancreatic Beta-Like Cells Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
12 Industry Chain Analysis
- 12.1 IPSC-Derived Pancreatic Beta-Like Cells Industry Chain
- 12.2 IPSC-Derived Pancreatic Beta-Like Cells Upstream Analysis
- 12.3 IPSC-Derived Pancreatic Beta-Like Cells Midstream Analysis
- 12.4 IPSC-Derived Pancreatic Beta-Like Cells Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on IPSC-Derived Pancreatic Beta-Like Cells. Industry analysis & Market Report on IPSC-Derived Pancreatic Beta-Like Cells is a syndicated market report, published as Global IPSC-Derived Pancreatic Beta-Like Cells Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of IPSC-Derived Pancreatic Beta-Like Cells market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
